Johnson Health Tech .Co., Ltd. (TPE:1736)
Taiwan · Delayed Price · Currency is TWD 128.50
+2.00 (1.58%)
Aug 26, 2026, 1:30 PM CST
Johnson Health Tech .Co. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 56,473 | 54,329 | 47,785 | 38,070 | 33,613 | 30,779 | |
Revenue Growth | 7.84% | 13.69% | 25.52% | 13.26% | 9.21% | 8.51% |
Cost of Revenue | 26,455 | 26,859 | 23,507 | 19,642 | 19,007 | 16,873 |
Gross Profit | 30,018 | 27,470 | 24,278 | 18,427 | 14,606 | 13,906 |
Selling, General & Admin | 24,096 | 22,634 | 19,746 | 15,986 | 13,890 | 12,559 |
Research & Development | 1,284 | 1,170 | 1,147 | 1,062 | 913.22 | 808.65 |
Operating Expenses | 25,469 | 23,878 | 21,086 | 17,185 | 14,821 | 13,752 |
Operating Income | 4,549 | 3,592 | 3,192 | 1,242 | -214.93 | 154.19 |
Interest Expense | -394.05 | -380.52 | -349.8 | -377.47 | -256.18 | -163.48 |
Interest & Investment Income | 445.17 | 351 | 311.52 | 194.19 | 165.17 | 152.41 |
Currency Exchange Gain (Loss) | 454.71 | 293.35 | 330.82 | 363.44 | 970.59 | -96.88 |
Other Non Operating Income (Expenses) | -426.56 | 80.31 | 29.19 | -63.71 | -132.27 | 90.84 |
EBT Excluding Unusual Items | 4,629 | 3,936 | 3,514 | 1,359 | 532.38 | 137.08 |
Gain (Loss) on Sale of Investments | 2.1 | 3.28 | -14.89 | -15.23 | -226.39 | 23.18 |
Gain (Loss) on Sale of Assets | -18.04 | -9.08 | -6.32 | -9.05 | -2.38 | 3.44 |
Pretax Income | 4,613 | 3,930 | 3,492 | 1,334 | 303.61 | 163.7 |
Income Tax Expense | 1,257 | 1,180 | 1,062 | 625.05 | 78.67 | 64.33 |
Earnings From Continuing Operations | 3,355 | 2,750 | 2,431 | 709.44 | 224.94 | 99.37 |
Minority Interest in Earnings | -0.85 | -0.62 | -0.47 | 0.39 | 204.08 | -61.22 |
Net Income | 3,354 | 2,749 | 2,430 | 709.83 | 429.02 | 38.15 |
Net Income to Common | 3,354 | 2,749 | 2,430 | 709.83 | 429.02 | 38.15 |
Net Income Growth | 25.91% | 13.14% | 242.36% | 65.45% | 1024.63% | -94.38% |
Shares Outstanding (Basic) | 303 | 303 | 303 | 303 | 303 | 303 |
Shares Outstanding (Diluted) | 304 | 304 | 303 | 303 | 303 | 303 |
Shares Change | 0.04% | 0.11% | 0.11% | 0.10% | 0.01% | -0.02% |
EPS (Basic) | 11.06 | 9.06 | 8.02 | 2.34 | 1.42 | 0.13 |
EPS (Diluted) | 11.05 | 9.06 | 8.01 | 2.34 | 1.42 | 0.13 |
EPS Growth | 25.93% | 13.11% | 242.31% | 65.06% | 1024.49% | -94.37% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3,184 | 869.97 | 379.78 | 3,193 | -15.32 | -4,229 |
Free Cash Flow Per Share | 10.49 | 2.87 | 1.25 | 10.54 | -0.05 | -13.98 |
Dividend Per Share | 4.500 | 4.500 | 4.000 | 1.000 | 0.600 | 0.500 |
Dividend Growth | 12.50% | 12.50% | 300.00% | 66.67% | 20.00% | -55.36% |
Gross Margin | 53.15% | 50.56% | 50.81% | 48.40% | 43.45% | 45.18% |
Operating Margin | 8.06% | 6.61% | 6.68% | 3.26% | -0.64% | 0.50% |
Profit Margin | 5.94% | 5.06% | 5.09% | 1.86% | 1.28% | 0.12% |
Free Cash Flow Margin | 5.64% | 1.60% | 0.80% | 8.39% | -0.05% | -13.74% |
EBITDA | 5,204 | 4,224 | 3,852 | 1,812 | 323.24 | 637.49 |
EBITDA Margin | 9.21% | 7.77% | 8.06% | 4.76% | 0.96% | 2.07% |
D&A For EBITDA | 654.99 | 631.98 | 660.37 | 569.66 | 538.17 | 483.3 |
EBIT | 4,549 | 3,592 | 3,192 | 1,242 | -214.93 | 154.19 |
EBIT Margin | 8.06% | 6.61% | 6.68% | 3.26% | -0.64% | 0.50% |
Effective Tax Rate | 27.26% | 30.02% | 30.40% | 46.84% | 25.91% | 39.30% |